Market Insights
Our life sciences market insights offer posts for clients seeking exceptional hires.
The most expensive executive hire may be the one everyone agreed on (10/9/2026) - There is a particular moment in an executive search when everything appears to line up. The candidate has the right experience. The résumé makes sense. The references are strong. The interviews go well. The compensation is within range. The board likes the person. The CEO sees the potential. The leadership team can imagine working with … Continue reading "The most expensive executive hire may be the one everyone agreed on"
Do Public Biotech Companies in Major Indices Pay Executives More? (10/2/2026) - Do Public Biotech Companies in Major Indices Pay Executives More? We expected the answer to be yes. Public biotech companies included in major indices such as XBI, IBB, and NBI tend to be larger, more visible, and more heavily institutionally owned than many public biotech companies outside those indices. It seemed reasonable to expect those … Continue reading "Do Public Biotech Companies in Major Indices Pay Executives More?"
The executive who was perfect for the last five years may be wrong for the next five (10/2/2026) - A successful executive hire creates a natural temptation to stop questioning the appointment. The company grows. The executive delivers. The board gains confidence. The leadership team develops a rhythm. Years pass, and the executive becomes closely associated with the organization’s success. Then the business changes.For additional posts, please see our Blog.
↓ Stay connected with GeneCoda® on LinkedIn for updates and insights.
